These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4903799)

  • 1. The treatment of impotence with methyltestosterone thyroid (100 patients--double blind study).
    Jakobovits T
    Fertil Steril; 1970 Jan; 21(1):32-5. PubMed ID: 4903799
    [No Abstract]   [Full Text] [Related]  

  • 2. Afrodex and impotence.
    Med Lett Drugs Ther; 1968 Nov; 10(24):97-8. PubMed ID: 4881922
    [No Abstract]   [Full Text] [Related]  

  • 3. Afrodex in the treatment of male impotence: a double-blind cross-over study.
    Miller WW
    Curr Ther Res Clin Exp; 1968 Jul; 10(7):354-9. PubMed ID: 4969675
    [No Abstract]   [Full Text] [Related]  

  • 4. Afrodex vs. placebo in the treatment of male impotence: statistical analysis of two double-blind crossover studies.
    Roberts CD; Sloboda W
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):96-9. PubMed ID: 4203851
    [No Abstract]   [Full Text] [Related]  

  • 5. An evaluation of Afrodex in the management of male impotency: a double-blind crossover study.
    Sobotka JJ
    Curr Ther Res Clin Exp; 1969 Feb; 11(2):87-94. PubMed ID: 4975819
    [No Abstract]   [Full Text] [Related]  

  • 6. TREATMENT OF IMPOTENCE WITH A METHYLTESTOSTERONE-THYROID COMPOUND.
    DUBIN MF
    West Med Med J West; 1964 Feb; 5():67-9. PubMed ID: 14119142
    [No Abstract]   [Full Text] [Related]  

  • 7. A controlled trial of Potensan Forte ("aphrodisiac" and testosterone combined) in impotence.
    Cooper AJ; Smith CG; Ismail AA; Loraine JA
    Ir J Med Sci; 1973 Jul; 142(4):155-61. PubMed ID: 4726287
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical studies on the use of Afrodex in the treatment of impotence: statistical summary of 4000 cases.
    Margolis R; Sangree H; Prieto P; Stein L; Chinn S
    Curr Ther Res Clin Exp; 1967 Apr; 9(4):213-9. PubMed ID: 4962695
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of studies on a mixture of nux vomica, yohimbine and methyl testosterone in the treatment of impotence.
    Margolis R; Leslie CH
    Curr Ther Res Clin Exp; 1966 May; 8(5):280-4. PubMed ID: 4956391
    [No Abstract]   [Full Text] [Related]  

  • 10. Lowering of H.D.L.-cholesterol by androgens.
    Masarei JR; Lynch WJ
    Lancet; 1977 Oct; 2(8042):827-8. PubMed ID: 71638
    [No Abstract]   [Full Text] [Related]  

  • 11. Methyltestosterone-induced cholestasis. The importance of disproportionately low serum alkaline phosphatase level.
    Borhan-Manesh F; Farnum JB
    Arch Intern Med; 1989 Sep; 149(9):2127-9. PubMed ID: 2774790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial of the medicinal combination composed of gamma-aminobutyric acid with methyltestosterone, used in the treatment of psychoneuroendocrine disorders].
    de Moraes JB; Tardy R
    Hospital (Rio J); 1965 Dec; 68(6):1423-9. PubMed ID: 5296038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of a drug combination composed of gamma-aminobutyric acid with methyltestosterone used in the treatment of psychoneuroendocrine disorders].
    de Moraes JB; Tardy R
    Hospital (Rio J); 1965 Dec; 68(6):1423-9. PubMed ID: 5295288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of methyltestosterone on the function of sexual glands].
    Korikov ML
    Vrach Delo; 1968 May; 5():100-2. PubMed ID: 5740428
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormonel therapy of patients with functional sexual disorders].
    Bakhur VT
    Vrach Delo; 1966 Dec; 12():109-10. PubMed ID: 6002693
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the therapy of potency disorders in liver diseases].
    Burgmann W
    Med Welt; 1968 Jul; 27():1592-4. PubMed ID: 5718204
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral androgens in the treatment of hypogonadal impotent men.
    Morales A; Johnston B; Heaton JW; Clark A
    J Urol; 1994 Oct; 152(4):1115-8. PubMed ID: 8072077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TH therapy of climacteric disorders with a physiologic regulatory drug].
    Lagatz WH
    Dtsch Med J; 1966 Jul; 17(14):426-7. PubMed ID: 5986008
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Oral androgens in the treatment of hypogonadal impotent men.
    Loughlin KR; O'Leary MP
    J Urol; 1995 May; 153(5):1645. PubMed ID: 7755797
    [No Abstract]   [Full Text] [Related]  

  • 20. Methyltestosterone-induced night blindness.
    Nisbett SB; Parker JA; Habal F
    Can J Ophthalmol; 1985 Dec; 20(7):254-6. PubMed ID: 3879195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.